Novel therapeutic strategies: hypomethylating agents and beyond.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 65-73

  Santini, Valeria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; LENALIDOMIDE; THALIDOMIDE;

AGED; ALGORITHM; CELL TRANSFORMATION; COMORBIDITY; CYTOGENETICS; DNA METHYLATION; ERYTHROPOIESIS; GENETICS; HEMATOLOGY; HUMAN; KARYOTYPING; METHODOLOGY; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PREDICTIVE VALUE; PROGNOSIS; REMISSION; REVIEW; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; CELL TRANSFORMATION, NEOPLASTIC; COMORBIDITY; CYTOGENETICS; DNA METHYLATION; ERYTHROPOIESIS; HEMATOLOGY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KARYOTYPING; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REMISSION INDUCTION; THALIDOMIDE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84875936604     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.65.3806843     Document Type: Review

References (0)